Literature DB >> 7739629

Early onset facioscapulohumeral muscular dystrophy.

O F Brouwer1, G W Padberg, E Bakker, C Wijmenga, R R Frants.   

Abstract

We report 10 patients (5 familial, 5 sporadic) with facioscapulohumeral muscular dystrophy (FSHD) with onset of facial and shoulder girdle weakness in early infancy. They showed the same broad range of clinical signs and symptoms as can be seen normally in FSHD. In 7 patients Southern blotting with p13E-11 was performed which showed an abnormal EcoRI fragment (13-22 kb) in 6 of them. We conclude that early onset FSHD does not differ from regular FSHD clinically or genetically. However, the precise mechanisms involved in the extensive clinical variability of the disease are still unknown.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739629

Source DB:  PubMed          Journal:  Muscle Nerve Suppl


  13 in total

1.  Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population.

Authors:  Miri Yanoov-Sharav; Esther Leshinsky-Silver; Sarit Cohen; Chana Vinkler; Marina Michelson; Tally Lerman-Sagie; Mira Ginzberg; Menahem Sadeh; Dorit Lev
Journal:  J Genet Couns       Date:  2011-11-23       Impact factor: 2.537

2.  Isolated facial diplegia and very late-onset myopathy in two siblings: atypical presentations of facioscapulohumeral dystrophy.

Authors:  Juan J Figueroa; John E Chapin
Journal:  J Neurol       Date:  2009-10-14       Impact factor: 4.849

3.  Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.

Authors:  Rianne J M Goselink; Karlien Mul; Caroline R van Kernebeek; Richard J L F Lemmers; Silvère M van der Maarel; Tim H A Schreuder; Corrie E Erasmus; George W Padberg; Jeffrey M Statland; Nicol C Voermans; Baziel G M van Engelen
Journal:  Neurology       Date:  2018-12-19       Impact factor: 9.910

4.  [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].

Authors:  B Jordan; C Müller-Reible; S Zierz
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 5.  Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation.

Authors:  Silvère M van der Maarel; Daniel G Miller; Rabi Tawil; Galina N Filippova; Stephen J Tapscott
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

6.  Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.

Authors:  Hiroaki Mitsuhashi; Satomi Mitsuhashi; Taylor Lynn-Jones; Genri Kawahara; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2012-10-29       Impact factor: 6.150

7.  Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.

Authors:  Ebe Pastorello; Michelangelo Cao; Carlo P Trevisan
Journal:  Clin Neurol Neurosurg       Date:  2011-11-12       Impact factor: 1.876

8.  Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).

Authors:  Mariaelena Pistoni; Lily Shiue; Melissa S Cline; Sergia Bortolanza; Maria Victoria Neguembor; Alexandros Xynos; Manuel Ares; Davide Gabellini
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

9.  Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.

Authors:  Ana Nikolic; Giulia Ricci; Francesco Sera; Elisabetta Bucci; Monica Govi; Fabiano Mele; Marta Rossi; Lucia Ruggiero; Liliana Vercelli; Sabrina Ravaglia; Giacomo Brisca; Chiara Fiorillo; Luisa Villa; Lorenzo Maggi; Michelangelo Cao; Maria Chiara D'Amico; Gabriele Siciliano; Giovanni Antonini; Lucio Santoro; Tiziana Mongini; Maurizio Moggio; Lucia Morandi; Elena Pegoraro; Corrado Angelini; Antonio Di Muzio; Carmelo Rodolico; Giuliano Tomelleri; Maria Grazia D'Angelo; Claudio Bruno; Angela Berardinelli; Rossella Tupler
Journal:  BMJ Open       Date:  2016-01-05       Impact factor: 2.692

Review 10.  Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.

Authors:  Anna Greco; Remko Goossens; Baziel van Engelen; Silvère M van der Maarel
Journal:  Clin Genet       Date:  2020-03-04       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.